Filing Details
- Accession Number:
- 0001140361-14-031349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-07 19:28:27
- Reporting Period:
- 2014-08-05
- Filing Date:
- 2014-08-07
- Accepted Time:
- 2014-08-07 18:28:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197355 | J Henry Fuchs | C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949 | Evp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-05 | 10,000 | $21.51 | 86,550 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-05 | 10,000 | $65.00 | 76,550 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) Common Stock | Disposition | 2014-08-05 | 10,000 | $0.00 | 10,000 | $21.51 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
54,155 | 2010-11-12 | 2020-05-11 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to 10b5-1 trading plan executed on December 13, 2013.
- All shares sold at exactly the same price.
- Options vest 6/48ths on November 12, 2010 and 1/48th on the 12th of each month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.